{"id":3483,"date":"2020-03-28T13:02:00","date_gmt":"2020-03-28T13:02:00","guid":{"rendered":"https:\/\/preprod.treefrog.fr\/?p=820"},"modified":"2020-03-28T13:02:00","modified_gmt":"2020-03-28T13:02:00","slug":"interview-jean-luc-treillou-co-founder-chairman-of-the-board-2","status":"publish","type":"post","link":"https:\/\/preprod.treefrog.fr\/interview-jean-luc-treillou-co-founder-chairman-of-the-board-2\/","title":{"rendered":"Interview : Jean-Luc Treillou, Co-Founder & Chairman of the Board"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
<\/div>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t

Following an international career in the pharma industry (GSK, Sanofi, Oenobiol), Jean-Luc Treillou co-founded microbiome company LNC therapeutics in 2011, eventually raising 16.5M\u20ac as CEO & Chairman. In 2018, he co-founded TreeFrog Therapeutics with Maxime Feyeux & Kevin Alessandri, taking in charge governance and investor relations as Chairman of the Board.<\/span>
<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

https:\/\/youtu.be\/Od1dhu8o228 Following an international career in the pharma industry (GSK, Sanofi, Oenobiol), Jean-Luc Treillou co-founded microbiome company LNC therapeutics in 2011, eventually raising 16.5M\u20ac as CEO & Chairman. In 2018, he co-founded TreeFrog Therapeutics with Maxime Feyeux & Kevin Alessandri, taking in charge governance and…<\/p>\n","protected":false},"author":1,"featured_media":1240,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"video","meta":{"_mi_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[12,15],"tags":[],"aioseo_notices":[],"yoast_head":"\nInterview : Jean-Luc Treillou, Co-Founder & Chairman of the Board - TreeFrog Therapeutics I iPS-derived cell therapies<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Interview : Jean-Luc Treillou, Co-Founder & Chairman of the Board - TreeFrog Therapeutics I iPS-derived cell therapies\" \/>\n<meta property=\"og:description\" content=\"https:\/\/youtu.be\/Od1dhu8o228 Following an international career in the pharma industry (GSK, Sanofi, Oenobiol), Jean-Luc Treillou co-founded microbiome company LNC therapeutics in 2011, eventually raising 16.5M\u20ac as CEO & Chairman. In 2018, he co-founded TreeFrog Therapeutics with Maxime Feyeux & Kevin Alessandri, taking in charge governance and...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/preprod.treefrog.fr\/interview-jean-luc-treillou-co-founder-chairman-of-the-board-2\/\" \/>\n<meta property=\"og:site_name\" content=\"TreeFrog Therapeutics I iPS-derived cell therapies\" \/>\n<meta property=\"article:published_time\" content=\"2020-03-28T13:02:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/preprod.treefrog.fr\/wp-content\/uploads\/2020\/03\/interview-jl-treillou-treefrog.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1118\" \/>\n\t<meta property=\"og:image:height\" content=\"629\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Piergueritona\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/preprod.treefrog.fr\/interview-jean-luc-treillou-co-founder-chairman-of-the-board-2\/\",\"url\":\"https:\/\/preprod.treefrog.fr\/interview-jean-luc-treillou-co-founder-chairman-of-the-board-2\/\",\"name\":\"Interview : Jean-Luc Treillou, Co-Founder & Chairman of the Board - TreeFrog Therapeutics I iPS-derived cell therapies\",\"isPartOf\":{\"@id\":\"https:\/\/preprod.treefrog.fr\/#website\"},\"datePublished\":\"2020-03-28T13:02:00+00:00\",\"dateModified\":\"2020-03-28T13:02:00+00:00\",\"author\":{\"@id\":\"https:\/\/preprod.treefrog.fr\/#\/schema\/person\/ab868aec652cf07c221b48c1dc91a220\"},\"breadcrumb\":{\"@id\":\"https:\/\/preprod.treefrog.fr\/interview-jean-luc-treillou-co-founder-chairman-of-the-board-2\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/preprod.treefrog.fr\/interview-jean-luc-treillou-co-founder-chairman-of-the-board-2\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/preprod.treefrog.fr\/interview-jean-luc-treillou-co-founder-chairman-of-the-board-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/preprod.treefrog.fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Interview : Jean-Luc Treillou, Co-Founder & Chairman of the Board\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/preprod.treefrog.fr\/#website\",\"url\":\"https:\/\/preprod.treefrog.fr\/\",\"name\":\"TreeFrog Therapeutics I iPS-derived cell therapies\",\"description\":\"Cell Therapy for All\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/preprod.treefrog.fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/preprod.treefrog.fr\/#\/schema\/person\/ab868aec652cf07c221b48c1dc91a220\",\"name\":\"Piergueritona\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/preprod.treefrog.fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5270054e7ba7a649b1bc59c924e224e1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5270054e7ba7a649b1bc59c924e224e1?s=96&d=mm&r=g\",\"caption\":\"Piergueritona\"},\"sameAs\":[\"https:\/\/preprod.treefrog.fr\"],\"url\":\"https:\/\/preprod.treefrog.fr\/author\/piergueritona\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Interview : Jean-Luc Treillou, Co-Founder & Chairman of the Board - TreeFrog Therapeutics I iPS-derived cell therapies","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Interview : Jean-Luc Treillou, Co-Founder & Chairman of the Board - TreeFrog Therapeutics I iPS-derived cell therapies","og_description":"https:\/\/youtu.be\/Od1dhu8o228 Following an international career in the pharma industry (GSK, Sanofi, Oenobiol), Jean-Luc Treillou co-founded microbiome company LNC therapeutics in 2011, eventually raising 16.5M\u20ac as CEO & Chairman. In 2018, he co-founded TreeFrog Therapeutics with Maxime Feyeux & Kevin Alessandri, taking in charge governance and...","og_url":"https:\/\/preprod.treefrog.fr\/interview-jean-luc-treillou-co-founder-chairman-of-the-board-2\/","og_site_name":"TreeFrog Therapeutics I iPS-derived cell therapies","article_published_time":"2020-03-28T13:02:00+00:00","og_image":[{"width":1118,"height":629,"url":"https:\/\/preprod.treefrog.fr\/wp-content\/uploads\/2020\/03\/interview-jl-treillou-treefrog.jpg","type":"image\/jpeg"}],"author":"Piergueritona","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/preprod.treefrog.fr\/interview-jean-luc-treillou-co-founder-chairman-of-the-board-2\/","url":"https:\/\/preprod.treefrog.fr\/interview-jean-luc-treillou-co-founder-chairman-of-the-board-2\/","name":"Interview : Jean-Luc Treillou, Co-Founder & Chairman of the Board - TreeFrog Therapeutics I iPS-derived cell therapies","isPartOf":{"@id":"https:\/\/preprod.treefrog.fr\/#website"},"datePublished":"2020-03-28T13:02:00+00:00","dateModified":"2020-03-28T13:02:00+00:00","author":{"@id":"https:\/\/preprod.treefrog.fr\/#\/schema\/person\/ab868aec652cf07c221b48c1dc91a220"},"breadcrumb":{"@id":"https:\/\/preprod.treefrog.fr\/interview-jean-luc-treillou-co-founder-chairman-of-the-board-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/preprod.treefrog.fr\/interview-jean-luc-treillou-co-founder-chairman-of-the-board-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/preprod.treefrog.fr\/interview-jean-luc-treillou-co-founder-chairman-of-the-board-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/preprod.treefrog.fr\/"},{"@type":"ListItem","position":2,"name":"Interview : Jean-Luc Treillou, Co-Founder & Chairman of the Board"}]},{"@type":"WebSite","@id":"https:\/\/preprod.treefrog.fr\/#website","url":"https:\/\/preprod.treefrog.fr\/","name":"TreeFrog Therapeutics I iPS-derived cell therapies","description":"Cell Therapy for All","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/preprod.treefrog.fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/preprod.treefrog.fr\/#\/schema\/person\/ab868aec652cf07c221b48c1dc91a220","name":"Piergueritona","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/preprod.treefrog.fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5270054e7ba7a649b1bc59c924e224e1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5270054e7ba7a649b1bc59c924e224e1?s=96&d=mm&r=g","caption":"Piergueritona"},"sameAs":["https:\/\/preprod.treefrog.fr"],"url":"https:\/\/preprod.treefrog.fr\/author\/piergueritona\/"}]}},"_links":{"self":[{"href":"https:\/\/preprod.treefrog.fr\/wp-json\/wp\/v2\/posts\/3483"}],"collection":[{"href":"https:\/\/preprod.treefrog.fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/preprod.treefrog.fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/preprod.treefrog.fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/preprod.treefrog.fr\/wp-json\/wp\/v2\/comments?post=3483"}],"version-history":[{"count":0,"href":"https:\/\/preprod.treefrog.fr\/wp-json\/wp\/v2\/posts\/3483\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/preprod.treefrog.fr\/wp-json\/wp\/v2\/media\/1240"}],"wp:attachment":[{"href":"https:\/\/preprod.treefrog.fr\/wp-json\/wp\/v2\/media?parent=3483"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/preprod.treefrog.fr\/wp-json\/wp\/v2\/categories?post=3483"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/preprod.treefrog.fr\/wp-json\/wp\/v2\/tags?post=3483"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}